May 15, 2019 / 12:30PM GMT
Operator
Welcome to the Johnson & Johnson 2019 Pharmaceutical Business Review Meeting.
A few logistics before the presentations begin. This review is being made available via webcast accessible through the Investor Relations section of the Johnson & Johnson website at investor.jnj.com. Today's presentations include forward-looking statements. These statements are based on the company's current expectations, and the company assumes no obligation to update any of the statements as a result of new information or future developments. We encourage you to review the cautionary statements in the presentation materials and in the company's SEC filings, including the most recently filed Form 10-K and 10-Q, which identify certain factors that could cause the company's actual results to differ materially from those projected.
Our SEC filings, along with reconciliations of non-GAAP financial measures utilized for today's discussion to the most comparable GAAP measure, are all available at investor.jnj.com. Additionally, a number of products that will be discussed today are being developed in
Johnson & Johnson to Host Pharmaceutical Business Review Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot